Talk to Treato
Home/Evaluate Treato
A SMALLER SCOPE. A BETTER BUYING DECISION.

Evaluate healthcare partner monitoring with Treato

Choose one partner question, a representative set of pages and the evidence your team needs. Build a discussion brief before you commit to wider coverage.

Build your scope ↓Coverage, costs and security →
YOUR FIRST MONITORING BRIEF

Build your healthcare monitoring brief

This planner runs in your browser. It does not scan, confirm availability or send an enquiry. Use non-confidential metadata only, never patient data or reference documents.

Add reference context (optional)+

These details stay on this page unless downloaded or transferred to the enquiry form. No automatic saving.

Sources you want assessed

Requested coverage only. Confirm platform, format, language, access and cadence in writing.

DISCUSSION BRIEFNot a quote
Pharma & biotech

Approved claim and reference changes

1 to 25 partners · country to agree

Reference to bring
Medicine, classification, intended audience and country; approved claim reference ID, version, effective date and owner.
Question to test
Can a reviewer trace changed wording to the correct reference and keep the decision in the existing approval process?
Sources to assess
Public websites. Availability to confirm.
Keep the boundary clear
A reference match is not permission to promote. Marketing oversight is not safety intake, medical/legal approval or a validated regulatory record system.
Discuss this scope →

This is a planning document, not monitored evidence. “Discuss this scope” prepares an editable enquiry; only Send enquiry transmits it.

A CHECK IS NOT THE SAME AS A CLEAN RESULT

How to assess monitoring coverage and gaps

Agree a source list and ask for coverage status alongside findings. These are the distinctions to require in an evaluation, not a live monitoring report.

COVERAGE REVIEWDemo data
Source requestedObservationNext action
Public comparison pageChecked · wording differsRoute the captured claim to the reviewer.
Distributor pageBlocked · not assessedRecord the access gap. Agree an authorised next step.
Second language variantIn scope · not yet attemptedKeep it in the denominator and schedule the check.
Private creator storyNot in agreed scopeConfirm access and format support before adding it.
A failed recheck does not close a finding. Preserve the last observed evidence and its check time; the customer reviewer accepts the specific correction after a successful re-observation.
DECIDE WHAT SUCCESS MEANS FIRST

Agree useful monitoring evaluation measures

Agree the sample, baseline, evaluation window and pass criteria first. Suggested measures, not Treato performance claims.

01

Usable coverage

Assessed sources divided by agreed in-scope URL, locale and product variants. Keep blocked and unattempted sources in the denominator; track discoveries and out-of-scope pages separately.

Can we see enough?
02

Reviewer usefulness

Actionable findings divided by adjudicated findings. Show raw observations, unique findings, repeats and unresolved items separately; growth opportunities are not compliance findings.

Is it worth opening?
03

Review workload

Compare minutes on the same sample with the manual process. Include reference maintenance, duplicate triage and false-positive handling, not just decision clicks.

Does it save effort?
04

Accepted corrections

Customer-accepted corrections divided by corrections due for recheck. Record partner response, successful re-observation and reviewer acceptance separately. No whole-page or whole-funnel compliance verdict.

Did the page change?
BEFORE YOU BUY

Pricing, procurement and service-scope questions

Start with public URLs and non-confidential metadata. Agree a secure transfer route before sharing proprietary reference packs or connecting a feed.

Read the data boundaries →
How is pricing scoped?

Ask for a proposal tied to partners and pages, markets, supported sources, cadence, reference maintenance and delivery. Confirm onboarding, rechecks, exports, API work and expansion costs. No standard price, free pilot or fixed turnaround is published here.

What should an evaluation agree?

A source list and reference metadata, named reviewer and partner owner, supported formats and languages, start and end dates, success measures, costs and exit terms. Confirm actual workflow and delivery options before signing.

How do we avoid a noisy alert queue?

Include unchanged pages, harmless edits, repeated wording and blocked sources in the test. Ask how findings are grouped, dismissed and reopened after a material change. Do not assume automatic deduplication or suppression without a demonstration.

What does procurement need to verify?

Customer-service hosting and residency, subprocessors, DPA, access roles and authentication, audit history, export and retention/deletion, incident handling and assurance reports. Website enquiry controls do not prove those service controls. Confirm each requirement and gap in writing.

Will this replace our existing systems?

No. Keep approval, safety reporting, attribution and customer systems. Agree the receiving system and handoff fields, then confirm whether delivery is a report, export or integration. No named native integration is implied.

Is health insurance supported?

The insurance choice is an adjacent fit check only. Public broker wording and accessible redirects may be relevant. Visible form wording needs its own access assessment; post-submit flows, consent records, calls and enrollment are not demonstrated coverage. A page capture or downloaded brief cannot prove valid consent or permission to contact a lead.

Use sector examples to define your brief

Choose the relevant context: pharma and biotech, telehealth and online pharmacy, consumer health or diagnostics and healthcare services. Compare the example monitoring records with the evidence and next actions your team would need.